| 101 |
Structure-based design, synthesis, and biological evaluation of novel piperine–resveratrol hybrids as antiproliferative agents targeting SIRT-2 |
2021 |
| 102 |
Synthesis, and biological evaluation of new series of pyrrol-2(3H)-one and pyridazin-3(2H)-one derivatives as tubulin polymerization inhibitors |
2021 |
| 103 |
Synthesis, Characterization, and Antifungal Activity of Some New Thieno[2,3-b]pyridines Incorporating Quinazoline or Benzimidazole Moiety |
2021 |
| 104 |
The protein tyrosine phosphatase SHP-1 (PTPN-6) but not CD45 (PTPR-C) is essential for the ligand-mediated regulation of CD22 in BCR-ligated B cells |
2021 |
| 105 |
A Facile Synthesis, Drug‑Likeness, and In Silico Molecular Docking of Certain New Azidosulfonamide–Chalcones and Their In Vitro Antimicrobial Activity |
2020 |
| 106 |
A Hybrid In Silico/In Vitro Target Fishing Study to Mine
Novel Targets of Urolithin A and B: A Step Towards a Better
Comprehension of Their Estrogenicity |
2020 |
| 107 |
Antimicrobial Pyridazines: Synthesis, Characterization, Cytotoxicity, Substrate Promiscuity, and Molecular Docking |
2020 |
| 108 |
CK2 Inhibition, Lipophilicity and Anticancer Activity of New N1 Versus N2-Substituted Tetrabromobenzotriazole Regioisomers |
2020 |
| 109 |
CK2 Inhibition, Lipophilicity and Anticancer Activity of New N1 Versus N2-Substituted Tetrabromobenzotriazole Regioisomers |
2020 |
| 110 |
Click chemistry synthesis, biological evaluation and docking study of some novel 2′-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents. |
2020 |
